• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Carrot, Oura, Dexcom partner on biosensor insights for fertility

November 13, 2025 By Sean Whooley

A person wears the Oura ring while scrolling the app looking at glucose values.
An Oura ring user looks at glucose values on the app. [Image courtesy of Dexcom/Oura]
Carrot announced that it partnered with Oura and Dexcom to deliver actionable, personalized insights supporting fertility goals.

The companies came together to provide actionable, personalized insights through the metabolic-fertility program, Sprints. This collaboration combines Carrot’s clinical expertise with advanced insights from Oura, a leading smart wearable ring maker, and Dexcom, a leading continuous glucose monitor (CGM) maker.

Dexcom and Oura have a pre-existing partnership, officially launching an integration with the Dexcom Stelo sensor earlier this year. Stelo, the company’s FDA-cleared over-the-counter (OTC) glucose biosensor, now gives users 24/7 glucose insights via the Oura app. Oura’s new in-app metabolic health feature, Glucose, now gives Oura members a deeper understanding of how dietary choices impact health.

With Carrot, the two plan to deliver insights to empower Carrot members to understand. their bodies and optimize their health and wellness.

Through the partnership, Carrot plans for its members to gain access to integrated Oura Ring data that tracks activity, sleep, stress, cardiovascular and women’s health biometrics, plus glucose data through a first-of-its-kind integration with Stelo. These metrics can help users better navigate their journeys across fertility and trying to conceive. The partnership strengthen’s Carrot’s clinically-backed metabolic-fertility program, which helps members overcome fertility obstacles caused by obesity, blood sugar dysregulation, sperm damage, and other common markers of metabolic disorder.

Carrot said its clinical treams, trained on Oura and Dexcom Stelo data interpretation, can translate wearable technology into actionable insights. These insights can drive personalized care planning and ongoing progress assessements. Integrating biometric data into the care journey can create optimal health outcomes.

Sprints participants can access Oura Ring and Stelo devices starting this month. Carrot, Oura and Dexcom expect data integrations in early 2026.

“A new wave of consumer health innovation is shining a spotlight on women’s health and hormonal health. Putting data in the hands of our members is an important first step, but it needs to be paired with actionable support from experts to improve health outcomes,” said Hilary Bartlett, chief product officerfficer of Carrot. “This partnership builds on our pioneering work in metabolic-fertility health and further supports our commitment to delivering results for employers and health plans.”

Filed Under: Business/Financial News, Diabetes, Featured, Patient Monitoring, Technology, Women's Health Tagged With: carrot, Dexcom, Oura

IN CASE YOU MISSED IT

  • Dexcom Q3 earnings top forecasts, as it looks ahead to type 2 coverage
  • Sensonics launches human feasibility study for transmitter-free Eversense CGM
  • Enable Injections, Sanofi obtain approval for on-body myeloma therapy in Japan
  • Abbott sets Libre Duo glucose-ketone sensor US launch for December
  • Sequel Med Tech’s automated twiist pump scores FDA clearance in type 2 diabetes

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS